VISTIN PHARMA ASA (VISTN.OL) Stock Price & Overview

OSL:VISTN • NO0010734122

21.6 NOK
+0.1 (+0.47%)
Last: Mar 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

The current stock price of VISTN.OL is 21.6 NOK. Today VISTN.OL is up by 0.47%. In the past month the price increased by 6.4%. In the past year, price decreased by -10%.

VISTN.OL Key Statistics

52-Week Range19.4 - 27.3
Current VISTN.OL stock price positioned within its 52-week range.
1-Month Range20 - 23.5
Current VISTN.OL stock price positioned within its 1-month range.
Market Cap
957.744M
P/E
12.27
Fwd P/E
N/A
EPS (TTM)
1.76
Dividend Yield
6.04%

VISTN.OL Stock Performance

Today
+0.47%
1 Week
-3.57%
1 Month
+6.40%
3 Months
+9.09%
Longer-term
6 Months -7.30%
1 Year -10.00%
2 Years -3.14%
3 Years +16.76%
5 Years -15.29%
10 Years N/A

VISTN.OL Stock Chart

VISTIN PHARMA ASA / VISTN Daily stock chart

VISTN.OL Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to VISTN.OL. When comparing the yearly performance of all stocks, VISTN.OL is a bad performer in the overall market: 66.18% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
VISTN.OL Full Technical Analysis Report

VISTN.OL Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to VISTN.OL. VISTN.OL is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
VISTN.OL Full Fundamental Analysis Report

VISTN.OL Earnings

Next Earnings DateApr 24, 2026
Last Earnings DateFeb 12, 2026
PeriodQ4 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %
VISTN.OL Earnings History

VISTN.OL Forecast & Estimates


Analysts
Analysts40
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
VISTN.OL Forecast & Estimates

VISTN.OL Groups

Sector & Classification

Sub-Industry
Pharmaceuticals
Index Membership

VISTN.OL Financial Highlights

Over the last trailing twelve months VISTN.OL reported a non-GAAP Earnings per Share(EPS) of 1.76. The EPS increased by 27.2% compared to the year before.


Income Statements
Revenue(TTM)454.83M
Net Income(TTM)78.06M
Industry RankSector Rank
PM (TTM) 17.16%
ROA 18.36%
ROE 24.96%
Debt/Equity 0.07
Chartmill High Growth Momentum
EPS Q2Q%11.83%
Sales Q2Q%2.84%
EPS 1Y (TTM)27.2%
Revenue 1Y (TTM)7.38%
VISTN.OL financials

VISTN.OL Ownership

Ownership
Inst Owners14.16%
Shares44.34M
Float18.21M
Ins Owners4.89%
Short Float %N/A
Short RatioN/A
VISTN.OL Ownership

VISTN.OL Competitors/Peers

The largest stocks on the EU markets in the "Pharmaceuticals" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
SAN SANOFI9.04187.74B
SNW SANOFI9.04187.692B
1SAN SANOFI9.02187.378B
UNC UCB SA24.3851.176B
UCB UCB SA24.4150.164B
MRK MERCK KGAA12.8149.217B
BAYN BAYER AG-REG7.4537.111B
1BAYN BAYER AG-REG7.6536.973B
IPN IPSEN14.1113.795B
TUB FINANCIERE DE TUBIZE N/A10.059B
REC RECORDATI INDUSTRIA CHIMICA16.159.95B
VIRP VIRBAC SA16.32.907B
DMP DERMAPHARM HOLDING SE15.262.062B

Related stock screener links

View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Oslo Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges

About VISTN.OL

Company Profile

VISTN logo image Vistin Pharma ASA is a pharmaceutical company, which engages in the production of Metformin Active Pharmaceutical Ingredients (API). The company is headquartered in Oslo, Oslo. The company went IPO on 2015-06-10. The firm is engaged in the pharmaceuticals industry. The firm is a producer and supplier of Active Pharmaceutical Ingredients (APIs), which are used in medications for diabetes. Vistin Pharma offering such products: Metformin HCl (API); Metformin DC (direct compressible granules); Customized Particle Distribution (PSD) and Premix (Metformin + MgSt, can be delivered on-request). The Company’s customers are pharmaceutical companies worldwide.

Company Info

VISTIN PHARMA ASA

Ostensjoveien 27

Oslo OSLO NO

Employees: 73

VISTN Company Website

VISTN Investor Relations

Phone: 4748926506

VISTIN PHARMA ASA / VISTN.OL FAQ

What does VISTN do?

Vistin Pharma ASA is a pharmaceutical company, which engages in the production of Metformin Active Pharmaceutical Ingredients (API). The company is headquartered in Oslo, Oslo. The company went IPO on 2015-06-10. The firm is engaged in the pharmaceuticals industry. The firm is a producer and supplier of Active Pharmaceutical Ingredients (APIs), which are used in medications for diabetes. Vistin Pharma offering such products: Metformin HCl (API); Metformin DC (direct compressible granules); Customized Particle Distribution (PSD) and Premix (Metformin + MgSt, can be delivered on-request). The Company’s customers are pharmaceutical companies worldwide.


What is the current price of VISTN stock?

The current stock price of VISTN.OL is 21.6 NOK. The price increased by 0.47% in the last trading session.


What is the dividend status of VISTIN PHARMA ASA?

VISTIN PHARMA ASA (VISTN.OL) has a dividend yield of 6.04%. The yearly dividend amount is currently 0.


How is the ChartMill rating for VISTIN PHARMA ASA?

VISTN.OL has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


What is the market capitalization of VISTN stock?

VISTIN PHARMA ASA (VISTN.OL) has a market capitalization of 957.74M NOK. This makes VISTN.OL a Small Cap stock.